Dimitrios P. Mikhailidis

Dimitrios P. Mikhailidis's AcademicInfluence.com Rankings

Philosophy

#9787

World Rank

#13395

Historical Rank

Logic

#6745

World Rank

#8292

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Dimitrios P. Mikhailidis Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Dimitrios P. Mikhailidis's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

ESVS guidelines. Invasive treatment for carotid stenosis: indications, techniques. (2009) (580)
The impact of serum uric acid on cardiovascular outcomes in the LIFE study. (2004) (464)
The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study (2004) (383)
Letter by Paraskevas et al regarding article, "Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/american Stroke Association". (2011) (269)
Fibrinogen as a cardiovascular risk factor. (1997) (257)
Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. (2004) (217)
Efficacy and Safety of Atorvastatin in the Prevention of Cardiovascular End Points in Subjects With Type 2 Diabetes: The Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-Insulin-Dependent Diabetes Mellitus (ASPEN) (2006) (208)
"European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses. (2011) (196)
The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study (2002) (180)
Systematic review of antiplatelet therapy for the prevention of myocardial infarction, stroke or vascular death in patients with peripheral vascular disease (2001) (175)
“Is obesity linked to aging?” Adipose tissue and the role of telomeres (2012) (172)
The effect of smoking on arterial stiffness (2010) (156)
Ghrelin Can Bind to a Species of High Density Lipoprotein Associated with Paraoxonase* (2003) (154)
The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. (2004) (152)
Meta-analysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapy (2007) (147)
Low serum cholesterol and suicide (1992) (135)
Drug-induced fibrotic valvular heart disease (2009) (130)
Statin therapy reduces plasma endothelin-1 concentrations: A meta-analysis of 15 randomized controlled trials. (2015) (125)
Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non‐alcoholic fatty liver disease patients (2011) (120)
"European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses: executive summary. (2011) (116)
Intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1 at the early stages of atherosclerosis in a rat model. (2012) (101)
Can statins reduce perioperative morbidity and mortality in patients undergoing non-cardiac vascular surgery? (2006) (100)
Marital Status, Cardiovascular Diseases, and Cardiovascular Risk Factors: A Review of the Evidence. (2017) (95)
Early Benefit from Structured Care with Atorvastatin in Patients with Coronary Heart Disease and Diabetes Mellitus (2003) (94)
Serum uric acid levels and risk for acute ischaemic nonembolic stroke in elderly subjects (2005) (88)
Cardiovascular benefits of bariatric surgery in morbidly obese patients (2011) (87)
Plasma albumin and platelet function: relevance to atherogenesis and thrombosis. (1996) (85)
Effect of hypertension and its treatment on lipid, lipoprotein(a), fibrinogen, and bilirubin levels in patients referred for dyslipidemia. (1999) (84)
Statins: an essential component in the management of carotid artery disease. (2007) (80)
Effect of ezetimibe in patients who cannot tolerate statins or cannot get to the low density lipoprotein cholesterol target despite taking a statin (2007) (80)
Fenofibrate: metabolic and pleiotropic effects. (2005) (77)
Emerging indications for statins: a pluripotent family of agents with several potential applications. (2007) (74)
A cross-sectional study of the effects of hormon replacement therapy on the cardiovascular disease risk profile in healthy postmenopausal women. (2002) (73)
Effect of statins and ACE inhibitors alone and in combination on clinical outcome in patients with coronary heart disease (2004) (71)
High prevalence of metabolic syndrome and cardiovascular risk factors in men with ankylosing spondylitis on anti-TNFalpha treatment: correlation with disease activity. (2009) (70)
Lipoprotein (a) and stroke (2000) (70)
Does diabetes mellitus play a role in restenosis and patency rates following lower extremity peripheral arterial revascularization? A critical overview. (2008) (66)
Cigarette smoking and erectile dysfunction (1998) (62)
Effect of atorvastatin on highdensity lipoprotein cholesteroland its relationship withcoronary events: a subgroupanalysis of the GREekAtorvastatin and Coronary-heart-disease Evaluation (GREACE) Study (2004) (60)
Value of Thromboelastography in the Assessment of Platelet Function (2003) (58)
Definition of Best Medical Treatment in Asymptomatic and Symptomatic Carotid Artery Stenosis (2016) (57)
Lipoprotein a: where are we now? (2009) (57)
Head-to-head comparison of statins versus fibrates in reducing plasma fibrinogen concentrations: A systematic review and meta-analysis. (2016) (56)
Why calls for more routine carotid stenting are currently inappropriate: an international, multispecialty, expert review and position statement. (2013) (56)
Smoking Diminishes the Beneficial Effect of Statins: Observations from the Landmark Trials (2001) (55)
Nutrition During Pregnancy and the Effect of Carbohydrates on the Offspring’s Metabolic Profile: In Search of the “Perfect Maternal Diet” (2011) (55)
The effect of peripheral vascular disease on the serum levels of natural anti-oxidants: bilirubin and albumin. (2002) (54)
Lipid-lowering drugs acting at the level of the gastrointestinal tract. (2009) (54)
HDL-cholesterol and the treatment of coronary heart disease: contrasting effects of atorvastatin and simvastatin. (2000) (53)
Prevalence of statin intolerance: a meta-analysis (2022) (53)
Dyslipidemia as a risk factor for erectile dysfunction. (2007) (52)
Comparison of the five 2011 guidelines for the treatment of carotid stenosis. (2012) (51)
Liver enzymes: potential cardiovascular risk markers? (2011) (51)
Renal function impairment in peripheral arterial disease: an important parameter that should not be neglected. (2009) (50)
Prothrombotic and lipoprotein variables in patients attending a cardiovascular risk management clinic: response to ciprofibrate or lifestyle advice. (1998) (50)
The role of fibrinogen and fibrinolysis in peripheral arterial disease. (2008) (50)
Internal Carotid Artery Occlusion: Association With Atherosclerotic Disease in Other Arterial Beds and Vascular Risk Factors (2007) (49)
Clustering of cardiovascular risk factors in rheumatoid arthritis: the rationale for using statins. (2007) (48)
Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe (2006) (47)
Impact of metabolic syndrome in surgical patients: should we bother? (2015) (44)
Ankle—Brachial Index: A Marker of Both Peripheral Arterial Disease and Systemic Atherosclerosis As Well As a Predictor of Vascular Events (2010) (43)
Mechanisms to explain the poor results of carotid artery stenting (CAS) in symptomatic patients to date and options to improve CAS outcomes. (2010) (42)
Peripheral arterial disease: a missed opportunity to administer statins so as to reduce cardiac morbidity and mortality. (2005) (42)
Subclinical hypothyroidism and vascular risk: An update (2013) (42)
Oxidative Stress As A Common Mediator for Apoptosis Induced-Cardiac Damage in Diabetic Rats (2008) (41)
C-reactive protein (CRP): more than just an innocent bystander? (2008) (40)
Perioperative/periprocedural effects of statin treatment for patients undergoing vascular surgery or endovascular procedures: an update. (2012) (38)
ESVS Guidelines: Section A--prevention in patients with carotid stenosis. (2010) (38)
Welcome to CMRO’s 40th Anniversary Issue (2012) (37)
Oral and ocular/orbital manifestations of temporal arteritis: a disease with deceptive clinical symptoms and devastating consequences (2007) (37)
The Treatment of Hypertension in Patients with Erectile Dysfunction (2000) (34)
Ezetimibe; more than a low density lipoprotein cholesterol lowering drug? An update after 4 years. (2011) (33)
Lipids and stroke: neglect of a useful preventive measure? (1998) (33)
Statin + fibrate combination therapy fluvastatin with bezafibrate or ciprofibrate in high risk patients with vascular disease. (1999) (32)
Critique of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST): flaws in CREST and its interpretation. (2013) (32)
Bilirubin Levels and Their Association with Carotid Intima Media Thickness and High-Sensitivity C-reactive Protein in Patients with Psoriasis Vulgaris (2014) (31)
Apolipoprotein J and leptin levels in patients with coronary heart disease. (2008) (31)
Carotid Bifurcation Geometry and Atherosclerosis (2017) (31)
Increased Urinary Excretion of Podocyte Markers in Normoalbuminuric Patients with Diabetes (2015) (31)
Thromboangiitis Obliterans (Buerger’s Disease): Searching for a Therapeutic Strategy (2007) (30)
Non-low-density lipoprotein cholesterol-associated actions of ezetimibe: an overview (2006) (30)
Fibrinogen, lipoprotein (a), albumin and bilirubin (F-L-A-B) levels and cardiovascular risk calculated using the Framingham equation. (2007) (30)
Lipoprotein (a) does not participate in the early acute phase response to training or extreme physical activity and is unlikely to enhance any associated immediate cardiovascular risk. (2002) (30)
Leptin: a promising therapeutic target with pleiotropic action besides body weight regulation. (2006) (29)
Atherosclerotic Renal Artery Stenosis: Association with Emerging Vascular Risk Factors (2007) (29)
The Impact of Lower Extremity Venous Ulcers due to Chronic Venous Insufficiency on Quality of Life (2008) (29)
Cardiovascular risk assessment of South Asians in a religious setting: a feasibility study (2012) (28)
Dyslipidaemia in 2013: New statin guidelines and promising novel therapeutics (2014) (28)
Influence of Oscillating Flow on LDL Transport and Wall Shear Stress in the Normal Aortic Arch (2009) (27)
Are Statins an Option in the Management of Abdominal Aortic Aneurysms? (2008) (27)
Atrial fibrillation, inflammation and statins. (2006) (27)
The role of cilostazol in the treatment of intermittent claudication (2004) (26)
Drug Treatment of Combined Hyperlipidemia (2001) (26)
Acute kidney injury: Short-term statin therapy for prevention of contrast-induced AKI (2014) (25)
Cardiovascular events in chronic dialysis patients: emphasizing the importance of vascular disease prevention (2010) (25)
Effect of statins and aspirin alone and in combination on clinical outcome in dyslipidaemic patients with coronary heart disease. A subgroup analysis of the GREACE study (2005) (25)
Statins and noncardiac vascular disease (2012) (25)
Pleiotropic effects of statins: implications for a wide range of diseases. (2008) (25)
The involvement of professional medical writers in medical publications (2005) (24)
Regulation of inducible nitric oxide synthase activity/expression in rat hearts from ghrelin-treated rats (2011) (24)
Second Consensus Conference on Cardiovascular Risk Factors and Erectile Dysfunction (2002) (23)
Contrast-Induced Acute Kidney Injury in Patients Undergoing Carotid Artery Stenting: An Underestimated Issue (2017) (23)
The role of established and emerging risk factors in peripheral vascular graft occlusion (2007) (23)
Optimal contemporary management of symptomatic and asymptomatic carotid artery stenosis (2011) (23)
Local Versus General Anesthesia for Carotid Endarterectomy (2012) (23)
Lipid lowering drugs and gallstones: a therapeutic option? (2011) (23)
Attaining United Kingdom-European Atherosclerosis Society Low-density Lipoprotein Cholesterol Guideline Target Values in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study (2002) (23)
Patients with peripheral arterial disease, abdominal aortic aneurysms and carotid artery stenosis are at increased risk for developing lung and other cancers. (2012) (23)
Prevalence of Metabolic Syndrome According to Different Definitions in a Hypertensive Population (2012) (23)
Effect of Atorvastatin on Serum Creatinine Levels (2001) (23)
Do Different Vascular Risk Factors Affect All Arteries Equally? (2008) (23)
Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease (2003) (23)
Vitamin D status and circulating biomarkers of endothelial dysfunction and inflammation in non-diabetic obese individuals: a pilot study (2016) (22)
Circulating plasma and platelet 5-hydroxytryptamine in carcinoid heart disease: a pilot study. (2013) (22)
The Rationale for Lowering the Size Threshold in Elective Endovascular Repair of Abdominal Aortic Aneurysm (2011) (22)
Optimal statin type and dosage for vascular patients. (2011) (22)
Ear lobe crease: a marker of coronary artery disease? (2015) (22)
Differences in metabolic parameters and cardiovascular risk between American Diabetes Association and World Health Organization definition of impaired fasting glucose in European Caucasian subjects: a cross-sectional study (2013) (21)
Cholesterol Crystal Embolization: A Possible Complication of Peripheral Endovascular Interventions (2008) (21)
Contrast-Induced Nephropathy and the Vascular Patient (2010) (20)
Association Between Abnormal Uterine Artery Doppler Flow Velocimetry, Risk of Preeclampsia, and Indices of Arterial Structure and Function: A Pilot Study (2008) (20)
Incidence of end-stage renal disease in the elderly: a steadily rising global socioeconomic epidemic (2010) (20)
Excess body weight and risk of first‐ever acute ischaemic non‐embolic stroke in elderly subjects (2007) (20)
Direct measurement of hepatic tissue hypoxia by using a novel tcpO2/pCO2 monitoring system in comparison with near‐infrared spectroscopy (2002) (20)
Evaluation of Aortic Stiffness (Aortic Pulse–Wave Velocity) Before and After Elective Abdominal Aortic Aneurysm Repair Procedures: A Pilot Study# (2009) (20)
Association between plasma levels and immunolocalization of cytokines in heart valve lesions: a possible target for treatment? (2008) (20)
Predicting coronary heart disease risk using the Framingham and PROCAM equations in dyslipidaemic patients without overt vascular disease (2007) (19)
Early statin therapy in patients with acute coronary syndrome. (2005) (19)
The GALA Trial: Will It Influence Clinical Practice? (2009) (19)
Is bilirubin protective against coronary artery disease? (1994) (19)
M.455 Effect of statins and ACE inhibitors alone and in combination on clinical outcome in patients with coronary heart disease: A Greace substudy (2004) (19)
Effect of Antihypertensive Treatment on PlasmaFibrinogen and Serum HDL Levelsin Patients with Essential Hypertension (2005) (19)
Combination Antiplatelet Therapy in Patients with Peripheral Vascular Bypass Grafts (2004) (18)
Prevalence, Predictors, and Impact of Low High-Density Lipoprotein Cholesterol on in-Hospital Outcomes Among Acute Coronary Syndrome Patients in the Middle East (2011) (18)
Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: a Review of Shared Cardiometabolic Risk Factors (2022) (18)
Prothrombin Gene G20210A Mutation in Acute Deep Venous Thrombosis Patients with Poor Response to Warfarin Therapy (2009) (17)
Carotid intima-media thickness and ezetimibe: the end of a misunderstanding? (2011) (17)
Water Soluble Vitamin E Administration in Wistar Rats with Non-alcoholic Fatty Liver Disease (2012) (17)
Relationship between LDL-C and non-HDL-C levels and clinical outcome in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study (2004) (17)
Book Reviews : Computer Programme Review GraphPad InStat Version 2.04a, GraphPad Software, 10855 Valley Road, No 203 San Diego, California CA 92121, USA. $95.00. Discounts available for Universities and students; substantial discounts for multiple (1994) (16)
Low serum albumin: A neglected predictor in patients with cardiovascular disease. (2022) (15)
Periodontitis and abdominal aortic aneurysms: a random association or a pathogenetic link? (2009) (15)
Experimental models of abdominal aortic aneurysms: an overview. (2008) (15)
Management of Patients with Asymptomatic Carotid Stenosis May Need to Be Individualized: A Multidisciplinary Call for Action (2021) (15)
The prevalence of cardiovascular risk factors and cardiovascular disease among primary care patients in Poland: results from the LIPIDOGRAM2015 study. (2020) (15)
Radial Artery Catheterization for Percutaneous Vascular or Coronary Interventions: An Innocent Procedure? (2010) (15)
Lipid-Lowering Therapy in Patients with Peripheral Arterial Disease (2005) (14)
Myocardial perfusion scintigraphy in asymptomatic diabetic patients: a critical review (2010) (14)
Microalbuminuria: a neglected cardiovascular risk factor in non-diabetic individuals? (2013) (14)
Optimal Management of Asymptomatic Carotid Stenosis in 2021: The Jury is Still Out. An International, Multispecialty, Expert Review and Position Statement. (2021) (14)
Management of high triglycerides: what non-specialists in lipids need to know. (2005) (14)
Ciprofibrate versus gemfibrozil in the treatment of mixed hyperlipidemias : An open-label, multicenter study (2001) (14)
Why the United States Center for Medicare and Medicaid Services (CMS) should not extend reimbursement indications for carotid artery angioplasty/stenting. (2012) (14)
Should the Size Threshold for Elective Abdominal Aortic Aneurysm Repair be Lowered in the Endovascular Era? Yes (2010) (14)
Clinical significance of carotid bruits: an innocent finding or a useful warning sign? (2008) (14)
Thromboprophylaxis in Patients with COVID-19: Systematic Review of National and International Clinical Guidance Reports. (2021) (14)
Statins and infrainguinal vascular bypass procedures. (2012) (14)
The effects of antihypertensive therapy on haemostatic parameters. (2003) (13)
Ideal lipid profile and genes for an extended life span (2011) (13)
Increased risk for cardiovascular disease in patients with obstructive sleep apnoea syndrome‐chronic obstructive pulmonary disease (overlap syndrome) (2019) (13)
Effect of tibolone on markers of cardiovascular disease risk in postmenopausal women undergoing hemodialysis: a pilot study. (2004) (13)
ESVS Guidelines: Section B - diagnosis and investigation of patients with carotid stenosis. (2010) (13)
The effect of biological age on the metabolic responsiveness of mice fed a high-fat diet (2013) (13)
Na+/H+ exchanger-1: a link with atherogenesis? (2010) (13)
Lipid Profile, Low-Density Lipoprotein Oxidation and Ceruloplasmin in the Progeny of Families With a Positive History of Cardiovascular Diseases and/or Hyperlipidemia (2009) (12)
Carotid Artery Stenting May Be Losing the Battle against Carotid Endarterectomy for the Management of Symptomatic Carotid Artery Stenosis, But the Jury Is Still Out (2009) (12)
Vascular Dysfunction of COVID-19 Is Partially Reverted in the Long-Term (2022) (12)
Smoking, Abdominal Aortic Aneurysms, and Ischemic Heart Disease: Is There a Link? (2008) (12)
More on the effect of atorvastatin on plasma fibrinogen levels in primary hypercholesterolaemia. (2000) (12)
Comparison of Fibrate, Ezetimibe, Low- and High-Dose Statin Therapy for the Dyslipidemia of the Metabolic Syndrome in a Mouse Model (2011) (12)
Why the United States Center for Medicare and Medicaid Services (CMS) should not extend reimbursement indications for carotid artery angioplasty/stenting (2012) (11)
The importance of treating multiple cardiometabolic risk factors in patients with Type 2 diabetes (2007) (11)
Serum Leptin Levels in Patients Undergoing Carotid Endarterectomy: A Pilot Study (2009) (11)
Statin Treatment, Carotid Atherosclerotic Plaque Macrophage Infiltration and Circulating Inflammatory Markers (2008) (11)
Undertreatment of hypercholesterolemia (2010) (11)
CARDS on the table: should everybody with type 2 diabetes take a statin? (2005) (11)
Involvement of Signaling Molecules on Na+/H+ Exchanger-1 Activity in Human Monocytes (2010) (10)
The estrogenic burden on vascular risk in male-to-female transsexuals. (2010) (10)
Effect of Statins on Serum Apolipoprotein J and Paraoxonase-1 Levels in Patients With Ischemic Heart Disease Undergoing Coronary Angiography (2008) (10)
Statins and Venous Thromboembolism (2013) (10)
Rectus Sheath Hematoma: A Simplified Emergency Surgical Approach (2011) (10)
Effect of Antiplatelet Agents, Statins, and Other Drugs on Vascular Access Patency Rates (2012) (10)
Statins and venous thromboembolism: a novel effect of statins? (2009) (9)
Sildenafil: a Urologist's View (2000) (9)
Peripheral Arterial Disease and HIV-Positive Patients (2011) (9)
Cholesterol, carotid artery disease and stroke: what the vascular specialist needs to know (2020) (9)
Platelet activation, gamma-glutamyltransferase and stent restenosis: comment on the article by Ulus et al. (2007) (9)
The Relationship Between Circulating Fibrinogen and Lipoprotein (a) Levels in Patients With Primary Dyslipidemia (2007) (9)
Optimal medical management of peripheral arterial disease. (2007) (8)
Angiogenesis: a promising treatment option for peripheral arterial disease. (2008) (8)
Non-coronary atherosclerotic cardiovascular disease in patients with familial hypercholesterolaemia (2020) (8)
Appropriate Patient Selection for Carotid Revascularization Procedures is Urgently Needed (2018) (7)
The Impact of Impaired Renal Function on Long-Term Outcomes in Patients With Peripheral Arterial Disease (2010) (7)
Rationale for screening selected patients for asymptomatic carotid artery stenosis (2020) (7)
Screening for peripheral artery disease in dialysis patients: an opportunity for early disease detection and timely initiation of appropriate therapeutic measures (2011) (7)
ESVS Guidelines. Invasive treatment for carotid stenosis indications, techniques (2009) (7)
Chronic hind limb ischemia reduces myocardial ischemia-reperfusion injury in the rabbit heart by promoting coronary angiogenesis/arteriogenesis. (2010) (7)
Lipoprotein alterations and reduced growth hormone secretion: relationships with obesity and cardiovascular risk 1 (2012) (7)
Clopidogrel and vascular disease prevention (2004) (7)
Oxidative Stress in the Pathogenesis of Abdominal Aortic Aneurysms: A Possible Pathway for the Effect of Statins? (2010) (7)
The Molecular Basis of Penile Erection (2000) (7)
Albumin, Haemostasis and Cardiovascular Disease (1991) (7)
Ciprofibrate versus gemfibrozil in the treatment of mixed hyperlipidemias: an open-label, multicenter study. (2001) (7)
Is High-sensitivity C-reactive Protein Associated With Subclinical Peripheral Atherosclerosis? (2009) (7)
Anaesthetic techniques for carotid surgery (2009) (6)
Statin use in patients with chronic kidney disease stages 2–4: targeting beyond improved mortality rates (2009) (6)
Carotid Bifurcation Geometry as Assessed by Ultrasound is Associated with Early Carotid Atherosclerosis. (2018) (6)
Increased Fluorodeoxyglucose Uptake Following Endovascular Abdominal Aortic Aneurysm Repair: A Predictor of Endoleak? (2010) (6)
Statins and contrast-induced nephropathy: issues requiring further investigation. (2011) (6)
Ezetimibe/simvastatin single tablet versus rosuvastatin in patients with hypercholesterolemia (2006) (6)
Low serum cholesterol and suicide. (1992) (6)
Kidney Function and Estimated Vascular Risk in Patients with Primary Dyslipidemia (2009) (6)
Severe, but not moderate, carotid atherosclerosis may predict concomitant vascular disease in other arterial beds. (2010) (6)
Coronary events with lipid-lowering therapy: The AFCAPS/TexCAPS trial [1] (multiple letters) (1999) (5)
Response to Red Blood Cell Distribution Width Is a Predictor of Readmission in Cardiac Patients (2013) (5)
Gender‐based cardiometabolic risk evaluation in minority and non‐minority men grading the evidence of non‐traditional determinants of cardiovascular risk (2011) (5)
55. Fibrinogen and lipoprotein(α): associations in a population attending a cardiovascular risk clinic and effect of treatment with ciprofibrate (1996) (5)
Why do guidelines recommend screening for abdominal aortic aneurysms, but not for asymptomatic carotid stenosis? A Plea for a randomized controlled trial. (2022) (5)
Cilostazol for intermittent claudication. (2021) (5)
Statins: a sine qua non of the management of patients with abdominal aortic aneurysms. (2013) (5)
Erectile dysfunction: a warning sign of silent vascular disease (2009) (5)
Endovascular Abdominal Aortic Aneurysm Repair (EVAR) Procedures: Counterbalancing the Benefits With the Costs (2010) (5)
Platelet Activation in Bypass Surgery for Critical Limb Ischemia (2007) (5)
Erectile dysfunction: a marker of early coronary heart disease. (2007) (5)
More on carotid atherosclerosis and ezetimibe. (2017) (5)
Relationships of osteoprotegerin with albuminuria and asymmetric dimethylarginine in essential hypertension: integrating vascular dysfunction (2011) (5)
Statins may not prevent structural valve degeneration of aortic bioprosthetic valves, but should probably be prescribed to patients undergoing heart valve surgery nonetheless. (2010) (5)
Are Symptomatic Patients Appropriate Candidates For Carotid Artery Stenting? No (at Least Not At Present) (2010) (5)
Irradiation-Induced Carotid Artery Stenosis: A Preventable Complication of Neck Radiotherapy? (2009) (4)
The Differences in the Prevalence of Cardiovascular Disease, Its Risk Factors, and Achievement of Therapeutic Goals among Urban and Rural Primary Care Patients in Poland: Results from the LIPIDOGRAM 2015 Study (2021) (4)
Relationship between low-density lipoprotein cholesterol, lipid-lowering agents and risk of stroke: a meta-analysis of observational studies (n = 355,591) and randomized controlled trials (n = 165,988) (2022) (4)
Statins and Heart Failure (2008) (4)
Longitudinal Effects of Fenfluramine—Phentermine Use (2007) (4)
Inflammatory and Prothrombotic Biomarkers, DNA Polymorphisms, MicroRNAs and Personalized Medicine for Patients with Peripheral Arterial Disease (2022) (4)
The association between serum uric acid levels and 10-year cardiovascular disease incidence: results from the ATTICA prospective study. (2021) (4)
Contrast-induced nephropathy in non-cardiac vascular procedures, a narrative review: Part 1. (2021) (4)
Best medical treatment for a symptomatic carotid artery stenosis (2011) (4)
Duration of aortic cross-clamping during elective open abdominal aortic aneurysm repair operations and postoperative cardiac/renal function. (2010) (4)
A possible relationship between renal impairment and complications development in type 2 diabetes mellitus: a prospective, observational study in Italy. (2015) (4)
Why the United States Center for Medicare and Medicaid Services should not extend reimbursement indications for carotid artery angioplasty/stenting (2012) (4)
Effect of Statins on Renal Function in Patients With Peripheral Arterial Disease (2009) (4)
Narrative review on clinical considerations for patients with diabetes and COVID‐19: More questions than answers (2021) (4)
METEOR: aiming at the stars for asymptomatic carotid artery atherosclerosis? * (2007) (4)
Comparison of Recent Practice Guidelines for the Management of Patients With Asymptomatic Carotid Stenosis (2022) (4)
Alice through the Looking-glass: Can We Improve Peer Review? (2022) (4)
Why the US Center for Medicare and Medicaid Services Should Not Extend Reimbursement Indications for Carotid Artery Angioplasty/Stenting (2012) (4)
HDL-cholesterol and the Treatment of Coronary Heart Disease: Contrasting Effects of Atorvastatin and Simvastatin (2000) (4)
Atorvastatin in combination with ezetimibe and carotid atherosclerosis. (2014) (4)
The Association Between Abdominal Aortic Aneurysms With Cardiovascular and Noncardiovascular Diseases (2018) (4)
Cardiovascular safety of oncologic agents: a double-edged sword even in the era of targeted therapies – Part 2 (2018) (4)
Additional effects of statins in surgical patients. (2008) (3)
Time for new low density lipoprotein cholesterol (LDL-C) targets? (2017) (3)
Statins induce regression of carotid artery stenosis: Fact or fiction? (2016) (3)
Lipids and non-cardiac vascular disease: a lecture overview. (2012) (3)
Regarding "Progression of asymptomatic carotid stenosis despite optimal medical therapy". (2014) (3)
Critical Issues and Controversies in the Management of Patients With Carotid Artery Stenosis (2016) (3)
18F-Fluorodeoxyglucose Uptake in Abdominal Aortic Aneurysms: A Useful Biomarker of AAA Rupture Risk (2014) (3)
Multifocal arterial disease: clinical implications and management. (2020) (3)
Obesity and nonalcoholic fatty liver disease in type 1 diabetes mellitus patients. (2022) (3)
Foreword [ Current Vascular Pharmacology is 10 Years Old! ] (2012) (3)
Attaining United States and European Guideline LDL-C Levels with Simvastatin in Patients with Coronary Heart Disease (the GOALLS Study) (2000) (3)
Comment on "Long-term Prognosis After Elective Abdominal Aortic Aneurysm Repair is Poor in Women and Men: The Challenges Remain". (2020) (3)
Predictors of Abdominal Aortic Aneurysm (AAA) Growth and AAA Rupture Risk Besides AAA Size: Fact or Fiction? (2010) (3)
Lipoprotein (a) as a treatment target for cardiovascular disease prevention and related therapeutic strategies: a critical overview. (2021) (3)
Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention Study. (1999) (2)
P5409Low-carbohydrate diets and all-cause and cause-specific mortality: a population-based cohort study and pooling prospective studies (2018) (2)
Abdominal Aortic Aneurysm Repair in England and the United States. (2017) (2)
Primary prevention using statins: to be or not to be? (2010) (2)
Exorcising ghosts and unwelcome guests. (2006) (2)
A Call to Encourage Participation in the Reviewing Process: The REFEREE Acrostic. (2022) (2)
Glucagon-Like Peptide-1 Receptor Agonists and Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Obesity/Metabolic Syndrome, Prediabetes/Diabetes and Non-Alcoholic Fatty Liver Disease—Current Evidence (2022) (2)
Contrast-induced nephropathy in non-cardiac vascular procedures, a narrative review: Part 2. (2021) (2)
Correlations between platelet aggregation, fibrinolysis, peripheral and central serotonergic measures in subhuman primates. (1995) (2)
W09.203 The prevalence of the metabolic syndrome in Greece: The MetS-Greece study (2004) (2)
M.454 The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease: A Greace substudy (2004) (2)
Non-alcoholic fatty liver disease in children. (2022) (2)
Adherence to statin treatment: an important issue in clinical practice (2016) (2)
Experimental models for the study of drugs used to prevent and treat vascular diseases. (2008) (2)
Interpreting the Carotid Revascularization Endarterectomy Versus Stent Trial (CREST): Additional Trials Are Needed (2010) (2)
Optimal management of asymptomatic carotid stenosis in 2021: the jury is still out. An International, multispecialty, expert review and position statement. (2021) (2)
Aortic pulse wave velocity may have prognostic value not just for hypertension but also for abdominal aortic aneurysms. (2010) (2)
STATINS AND FIBRINOGEN. AUTHORS' REPLY (1998) (2)
Time to look beyond just lowering the serum concentration of low density lipoprotein - high density lipoprotein levels are also important (2001) (2)
Secondary Stroke Prevention in Polish Adults: Results from the LIPIDOGRAM2015 Study (2021) (2)
Endovascular versus Open Repair of Abdominal Aortic Aneurysms: Interpreting the Landmark United Kingdom EVAR 1 Results (2010) (2)
COMPARISON OF A POINT OF CARE CHOLESTEROL DEVICE AND LABORATORY ANALYSIS IN THE PREDICTION OF CARDIOVASCULAR DISEASE (2009) (2)
Additional Issues on Screening, Prevention, and Treatment of Abdominal Aortic Aneurysms (2013) (2)
Exorcising ghosts and unwelcome guests. Author's reply (2006) (1)
Statin use and renal function after aortic aneurysm repair procedures. (2021) (1)
Management of patients with asymptomatic carotid stenosis may need to be individualized: a multidisciplinary call for action. (2021) (1)
Arteriovenous Fistula Leading to Severe Tortuosity and Aneurysm Formation (2009) (1)
Additional advantages of pre‐operative statin use in patients undergoing non‐cardiac vascular surgery (2008) (1)
OP-218 Endocan: A Novel Inflammatory Indicator in Newly Diagnosed Hypertensive Patients? A pilot Study (2014) (1)
C-reactive protein levels and aortic aneurysmal disease progression after endovascular repair: The jury is still out. (2016) (1)
Leptin, cardiovascular diseases and type 2 diabetes mellitus (2018) (1)
Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP). (2023) (1)
Gout flares and intercritical gout: do they play a significant role in predicting cardiovascular events? (2022) (1)
Optimal periprocedural antithrombotic treatment in carotid interventions: An international, multispecialty, expert review and position statement (2022) (1)
Effect of statin therapy on plasma apolipoprotein C-III concentrations: a Systematic Review and Meta-Analysis of Randomized Controlled Trials (2018) (1)
115 Audit of elderly referrals to a lipid clinic (1997) (1)
Ezetimibe: A New Class of Cholesterol Lowering Drugs (2004) (1)
Critical Issues and Controversies in Carotid Artery Stenosis (2016) (1)
The burden of carotid-related strokes (2021) (1)
Combination therapy with ezetimibe: an alternative strategy to statin monotherapy in the management of patients with non-cardiac vascular disease. (2022) (1)
Drug-induced fi brotic valvular heart disease (2009) (1)
Lipoprotein (a) and fibrinogen: Relationships in a cardiovascular risk management clinic (1995) (1)
The Impact of Novel Treatment Modalities on the Therapeutic Approach of Cardiovascular Diseases (2009) (1)
Comment on: effect of pravastatin sodium and simvastatin on plasma fibrinogen level and blood rheology in type II hyperlipoproteinemia. (1996) (1)
Benefits and drawbacks of statins and non-statin lipid lowering agents in carotid artery disease. (2022) (1)
Implications of the timely diagnosis of lower extremity peripheral arterial disease. (2014) (1)
The year in hyperlipidaemia. (2021) (1)
Regarding "Estimating the risk of solid organ malignancy in patients undergoing routine computed tomography scans after endovascular aneurysm repair". (2012) (1)
W09.202 Multifactorial treatment approach in patients with coronary heart disease and the metabolic syndrome: A greace substudy (2004) (1)
Abdominal aortic aneurysm intervention: time to reconsider decision-making criteria? (2012) (1)
2154Apolipoprotein B/apolipoprotein A-I ratio is comparable with C-reactive protein in predicting cancer mortality: results from two multi-ethnic US populations (2019) (1)
eComment: Endovascular repair of ruptured abdominal aortic aneurysms: identifying issues which may be difficult to achieve. (2010) (1)
P5313The association between coffee and caffeine consumption and renal function: insight from individual-level data, Mendelian randomization, and meta-analysis (2019) (1)
Narrative Review of Carotid disease and the kidney (2020) (1)
Coronary Artery Bypass Grafting Combined with Open Versus Endovascular Abdominal Aortic Aneurysm Repair. (2016) (0)
M.453 Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: A Greace substudy (2004) (0)
Endovascular repair of abdominal aortic aneurysm. (2010) (0)
1446A greater healthy behaviors score is associated with a lower risk of all-cause and cause specific mortality: insight from two prospective multi-ethnic surveys (2019) (0)
Metabolic syndrome is associated with similar long-term prognosis in non-obese and obese patients. An analysis of 45 615 patients from the nationwide LIPIDOGRAM 2004-2015 cohort studies. (2023) (0)
Asymptomatic carotid stenosis and cognitive impairment. (2023) (0)
Epicardial, peripancreatic and other "orthotopic" excessive fat deposition in south Asians and Europeans: Are differences clinically relevant? (2023) (0)
Clarifying the rationale supporting selective screening for asymptomatic carotid artery stenosis. (2023) (0)
Fibrinogen, lipoprotein (a), albumin and bilirubin (F-L-A-B) levels as markers of cardiovascular risk load in patients with primary dyslipidaemia (1999) (0)
578 CVD SCREENING IN A FAITH BASED SETTING IMPROVES ACCESS (2011) (0)
The influence of hypertension and antihypertensive drugs on 'new' cardiovascular risk factors, in dyslipidaemic patients. (1999) (0)
Peripheral Arterial Disease and Emerging Biochemical Vascular Risk Factors (2007) (0)
2.P.275 Secondary prevention is the main basis of elderly referrals to a lipid clinic (1997) (0)
Serum bilirubin and albumin levels are markers of the extent of atherosclerosis in dyslipidaemic patients (2000) (0)
COWBOYS AND INDIAN A Doctor's First Year in Texas. (2022) (0)
Why the United States Center for Medicare and Medicaid Services (CMS) should not extend reimbursement indications for carotid artery angioplasty/stenting. (2012) (0)
Optimal Management of Asymptomatic Carotid Stenosis: Counterbalancing the Benefits with the Potential Risks (2022) (0)
Relationship between Low-Density Lipoprotein Cholesterol, Lipid Lowering Agents and the Risk of Stroke: A meta-analysis of Observational studies (n=355,591) and Randomized Controlled Trials (2022) (0)
Carotid Artery Pathology in Inflammatory Diseases (2021) (0)
Are serum uric acid levels predictors of cardiovascular risk? An update. (2023) (0)
Carotid artery stenting may be contraindicated in female patients with symptomatic carotid artery stenosis. (2011) (0)
Response to Low serum bilirubin concentrations are associated with impaired aortic elastic properties, but not impaired left ventricular diastolic function (2007) (0)
P5417Consumption of dairy product and its association with total and cause specific mortality - A population-based cohort study and meta-analysis (2018) (0)
Letter to the Editor (2007) (0)
Benign prostatic hyperplasia and hypertension. (1998) (0)
Long-term treatment effect of atorvastatin on high-density lipoprotein cholesterol relationship with coronary events (2003) (0)
Carotid Artery Stenting Has a Role in the Management of Asymptomatic Carotid Stenosis, but This Is Currently Small (2018) (0)
The influence of atorvastatin on parameters of inflammation left ventricular function, hospitalizations and mortality in patients with dilated cardiomyopathy – 5-year follow-up (2013) (0)
The Treatment of Coronary Heart Disease: An Update Part 5: Selected Comments and Questions Compiled by (2001) (0)
Severe hypertriglyceridaemia revisited (2013) (0)
Dietary patterns, plasma vitamins and Trans fatty acids are associated with peripheral artery disease (2017) (0)
All journals should include a correspondence section (2022) (0)
Epidemiology and Pathophysiology of Carotid Artery Disease (2011) (0)
ESVS Guidelines： Section A--Prevention in patients with carotid stenosis (2010) (0)
ALBUMIN, HEMOSTASIS AND CARDIOVASCULAR-DISEASE (1991) (0)
Survey of patients with familial hypercholestrolaemia in the context of the draft nice guidelines (2008) (0)
Dietary food patterns and glucose/insulin homeostasis: a cross-sectional study involving 24,182 adult Americans (2017) (0)
Adiposity mediates the association between whole grain consumption, glucose homeostasis and insulin resistance: findings from the US NHANES (2018) (0)
Cardiovascular Risk Factors and Peripheral Arterial Disease (2010) (0)
Orlistat in type III hyperlipidaemia (2000) (0)
Editorial: Your VISION Will Become Clear Only When You Look Into Your Heart. (2016) (0)
Abnormal uterine artery Doppler flow velocimetry and risk of pre-eclampsia/future cardiovascular disease (2017) (0)
Fasting among pregnant women with diabetes during Ramadan (2012) (0)
Editorial commentary Undertreatment of hypercholesterolemia (2010) (0)
P2626Higher dietary acids load is associated with higher likelihood of peripheral arterial disease among American adults (2018) (0)
The treatment of coronary heart disease: an update. Part 5: Selected comments and questions. (2001) (0)
Lipids and Peripheral Arterial Disease (2007) (0)
Hypouricemia in the syndrome of inappropriate antidiuretic hormone. (1980) (0)
1443Safety of red yeast rice supplementation: a systematic review and meta-analysis of randomized controlled trials (2019) (0)
Impact of ezetimibe coadministered with statins on cardiovascular events following acute coronary syndrome: a 3-year population-based retrospective cohort study in taiwan. (2011) (0)
Phenotype or genotype for diagnosis of FH (2007) (0)
Carotid Artery Stenosis and Heart Valve Surgery: A Complex Scenario (2011) (0)
Results Statins : Mechanism of Action With Special Relevance to Abdominal Aortic Aneurysms (2008) (0)
Could Lowering Phytosterol Absorption as Part of Lipid-Lowering Therapy Have a Beneficial Effect on Residual Risk? (2023) (0)
Statins and Cholesterol: How Low Can You Go? (2008) (0)
Current topics in thrombosis. (1993) (0)
Carotid artery stenting: "good news" or "bad news" for post-procedural cognitive function? (2012) (0)
Medical management of risk factors for vascular disease (2004) (0)
P1523Association of ideal cardiovascular health metrics with serum uric acid and inflammation: a population-base survey (2018) (0)
Fluvastatin in combination with bezafibrate or ciprofibrate for the treatment of dyslipidaemia in patients with established vascular disease (1999) (0)
Screening for asymptomatic carotid stenosis in patients with non-valvular atrial fibrillation. (2022) (0)
Incidence of contrast-induced acute kidney injury in patients with acute mesenteric ischemia and identification of potential predictive factors (2021) (0)
Correction to: Association of statin use and clinical outcomes in heart failure patients: a systematic review and meta-analysis (2020) (0)
An interaction between ghrelin and a species of high-density lipoprotein (2002) (0)
Editorial: the year in lipids and emerging risk factors. (2022) (0)
Editorial [Hot topic: Up-Date On Diagnosis And Treatment Of Thrombotic And Haemorragic Disorders Naples] (2009) (0)
Atherosclerotic renal artery stenosis: epidemiology and pathophysiology (2008) (0)
Fetal/Infant Origins of Adult Vascular Disease. (2020) (0)
Additional Effects of Statins in Surgical Patients. Author's reply (2008) (0)
Vascular surgical procedures in patients with familial hypercholesterolaemia: is it too late? (2020) (0)
45Association of types of dietary fats and all-cause and cause-specific mortality: a prospective cohort study and meta-analysis of prospective studies with 1,148,117 participants (2019) (0)
ESVS Guidelines：Section B Diagnosis and investigation of patients with carotid stenosis (2010) (0)
Adiposity mediates the association between bilirubin, glucose/insulin homeostasis and inflammation (2020) (0)
Thrombotic risk factors in diabetic patients (1999) (0)
Low serum cholesterol and suicide. Author's reply (1992) (0)
Role of fibrates in reducing coronary risk: a UK Consensus (2004) (0)
Introduction (2000) (0)
C‐reactive protein–albumin ratio and erectile dysfunction (2022) (0)
Death Rates Local Versus General Anesthesia for Carotid Endarterectomy : Issues Beyond Stroke , Myocardial (2011) (0)
A therapeutic dilema (2004) (0)
60 Features of Mediterranean Diet and Burden of Cardiovascular Disease (2010) (0)
Interrelationships between fibrinogen and lipid variables in a cardiovascular disease prevention clinic (1994) (0)
Q003 Effect of hypertension on lipid and fibrinogen levels in patients referred for dyslipidaemia (1998) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Dimitrios P. Mikhailidis?

Dimitrios P. Mikhailidis is affiliated with the following schools:

University College London

Dimitrios P. Mikhailidis's Academic­Influence.com Rankings

Why Is Dimitrios P. Mikhailidis Influential?

Dimitrios P. Mikhailidis's Published Works

Published Works

What Schools Are Affiliated With Dimitrios P. Mikhailidis?

Dimitrios P. Mikhailidis's AcademicInfluence.com Rankings